{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T11:11:03Z","timestamp":1760267463761},"reference-count":22,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[1995,4,1]],"date-time":"1995-04-01T00:00:00Z","timestamp":796694400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,27]],"date-time":"2019-12-27T00:00:00Z","timestamp":1577404800000},"content-version":"vor","delay-in-days":9036,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[1995,4]]},"DOI":"10.1093\/oxfordjournals.annonc.a059178","type":"journal-article","created":{"date-parts":[[2017,2,3]],"date-time":"2017-02-03T12:08:10Z","timestamp":1486123690000},"page":"321-323","source":"Crossref","is-referenced-by-count":10,"title":["Pushing the envelope: Informed consent in phase I trials"],"prefix":"10.1016","volume":"6","author":[{"given":"C.K.","family":"Daugherty","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.J.","family":"Ratain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Siegler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1093\/oxfordjournals.annonc.a059178_bb0005","series-title":"Ethics in Medicine. Historical Perspectives and Contemporary Concerns","article-title":"An introduction to the study of experimental medicine. 1865","author":"Bernard","year":"1977"},{"key":"10.1093\/oxfordjournals.annonc.a059178_bb0010","series-title":"Experimentation with Human Beings","author":"Katz","year":"1972"},{"key":"10.1093\/oxfordjournals.annonc.a059178_bb0015","series-title":"A History and Theory of Informed Consent","author":"Faden","year":"1986"},{"key":"10.1093\/oxfordjournals.annonc.a059178_bb0020","series-title":"Ethics and Regulation of Clinical Research","author":"Levine","year":"1986"},{"key":"10.1093\/oxfordjournals.annonc.a059178_bb0025","series-title":"Principles of Biomedical Ethics","author":"Beauchamp","year":"1983"},{"issue":"6","key":"10.1093\/oxfordjournals.annonc.a059178_bb0030","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1001\/archinte.1988.00380060149027","article-title":"Two models of implementing informed consent","volume":"148","author":"Lidz","year":"1988","journal-title":"Arch Intern Med"},{"key":"10.1093\/oxfordjournals.annonc.a059178_bb0035","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1056\/NEJM199401203300324","article-title":"Informed consent, cancer, and truth in prognosis","volume":"330","author":"Annas","year":"1994","journal-title":"NEJM"},{"key":"10.1093\/oxfordjournals.annonc.a059178_bb0040","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1093\/jnci\/85.20.1637","article-title":"Statistical and ethical issues in the design and conduct of phase I and II clinical trials of new anticancer agents","volume":"85","author":"Ratain","year":"1993","journal-title":"J Natl Cancer Inst"},{"key":"10.1093\/oxfordjournals.annonc.a059178_bb0045","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/BF00194562","article-title":"Response rates, duration of response and dose response effects in phase I studies","volume":"9","author":"Von Hoff","year":"1991","journal-title":"Invest New Drugs"},{"key":"10.1093\/oxfordjournals.annonc.a059178_bb0050","first-page":"1105","article-title":"Therapeutic responses in phase I trials of antineoplastic agents","volume":"70","author":"Estey","year":"1986","journal-title":"Cancer Treat Rep"},{"key":"10.1093\/oxfordjournals.annonc.a059178_bb0055","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1093\/oxfordjournals.annonc.a057716","article-title":"Responses and toxic deaths in phase I clinical trials","volume":"2","author":"Decoster","year":"1990","journal-title":"Ann Oncol"},{"key":"10.1093\/oxfordjournals.annonc.a059178_bb0060","first-page":"71","article-title":"Clinical drug development: An anlysis of phase II trials, 1970\u20131985","volume":"71","author":"Marsoni","year":"1987","journal-title":"Cancer Treat Rep"},{"key":"10.1093\/oxfordjournals.annonc.a059178_bb0065","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1200\/JCO.1984.2.7.849","article-title":"Informed consent for investigational chemotherapy: Patients\u2019 and physicians\u2019 perceptions","volume":"2","author":"Penman","year":"1984","journal-title":"J Clin Oncol"},{"key":"10.1093\/oxfordjournals.annonc.a059178_bb0070","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1200\/JCO.1994.12.10.2211","article-title":"Are informed consent forms that describe clinical oncology research protocols readable by most patients and their families","volume":"12","author":"Grossman","year":"1994","journal-title":"J Clin Oncol"},{"key":"10.1093\/oxfordjournals.annonc.a059178_bb0075","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1001\/jama.1983.03340190048030","article-title":"Readability of informed consent forms for research in a veterans administration medical center","volume":"250","author":"Baker","year":"1983","journal-title":"JAMA"},{"key":"10.1093\/oxfordjournals.annonc.a059178_bb0080","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1002\/1097-0142(197904)43:4<1549::AID-CNCR2820430449>3.0.CO;2-R","article-title":"Written informed consent in patients with breast cancer","volume":"43","author":"Muss","year":"1979","journal-title":"Cancer"},{"key":"10.1093\/oxfordjournals.annonc.a059178_bb0085","doi-asserted-by":"crossref","first-page":"5","DOI":"10.2307\/3563682","article-title":"Cohort-specific consent An honest approach to phase I clinical cancer studies","volume":"12","author":"Freedman","year":"1990","journal-title":"IRB"},{"issue":"4","key":"10.1093\/oxfordjournals.annonc.a059178_bb0090","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1093\/oxfordjournals.annonc.a059185","article-title":"Informed consent for phase I studies: Evaluation of quantity and quality of information provided to patients","volume":"6","author":"Tomamichel","year":"1995","journal-title":"Ann Oncol"},{"key":"10.1093\/oxfordjournals.annonc.a059178_bb0095","series-title":"J Clin Oncol","article-title":"Perceptions of cancer patients and their physicians involved in phase 1 trials","author":"Daugherty","year":"1995"},{"issue":"1","key":"10.1093\/oxfordjournals.annonc.a059178_bb0100","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2307\/3562488","article-title":"Do we need another advisory commission on human experimentation?","volume":"2","author":"Katz","year":"1995","journal-title":"Hast Center Rep"},{"issue":"7","key":"10.1093\/oxfordjournals.annonc.a059178_bb0105","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/0959-8049(94)90111-2","article-title":"Informed consent in European Multicenter randomized clinical trials \u2013 are patients really informed?","volume":"30A","author":"Williams","year":"1994","journal-title":"Eur J Cancer"},{"key":"10.1093\/oxfordjournals.annonc.a059178_bb0110","first-page":"662A","article-title":"A proposal for a new phase I clinical trial design: Patient choice dose cohort","volume":"41","author":"Daugherty","year":"1993","journal-title":"Clin Res"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419611907?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419611907?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/6\/4\/321\/701367\/6-4-321.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,20]],"date-time":"2020-02-20T20:13:07Z","timestamp":1582229587000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419611907"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,4]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1995,4]]}},"alternative-id":["S0923753419611907"],"URL":"https:\/\/doi.org\/10.1093\/oxfordjournals.annonc.a059178","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[1995,4]]}}}